EOM insights from ACCC and COA from Carevive

Carevive actively participated in two notable conferences, the ACCC Business Summit and the Community Oncology Alliance (COA) conference. These events brought cancer centers together to discuss business, technology, and policy, highlighting the need for innovative solutions in the face of nursing shortages, staff burnout, and the implementation of the new CMS model, the Enhancing Oncology Model. Reesa Sherin, a Clinical Strategist at Carevive, shared insights into the collaborations and synergies discovered during these conferences and highlighted the company’s role in supporting cancer centers in meeting the requirements of the enhanced oncology model.

Collaborative Solutions for Cancer Centers:
At the ACCC Business Summit, cancer centers united to find innovative ways to address current challenges, such as nursing shortages and staff burnout. The focus on the Enhancing Oncology Model and its implementation highlighted the need for support and guidance. Carevive stepped in, offering assistance in implementing the model, particularly in areas like electronic patient-reported outcomes (ePROs) and health-related social needs. By creating health-related social plans and addressing barriers to care, Carevive supports cancer centers in providing high-quality, patient-centered care.

Recent Episodes

In this episode of Inside Restoration & Recovery, host Martha Lewis welcomes Jason McClaren, Director of Facilities Operations at Reunion Rehabilitation Hospitals, to discuss the critical advantage of partnering with a restoration team experienced in healthcare. A former firefighter and military veteran, Jason has spent the last decade managing safety, risk, and emergency preparedness…

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…